Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
4.050
-0.220 (-5.15%)
At close: Aug 1, 2025, 4:00 PM
4.030
-0.020 (-0.49%)
After-hours: Aug 1, 2025, 4:45 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Immune-mediated Diseases and Cancer Therapeutics
7.00M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
7.00M